omada health will prescribe glp-1 drugs starting in 2026. drug demand leaves employers a bind over coverage Self-Efficacy For Long-Term GLP-1 Weight

reveal that GHRP-6 alone was associated with a peak growth hormone response around 60 mU/L, while the combination of GHRP-6 with full-length GHRH was reported to raise the peak to roughly 140 mU/L, or 7-fold higher than the highest physiological peaks

Nearly 80% of the surveyed employers involve their executive leadership in GLP-1 coverage decisions.

The results showed that all three doses of tirzepatide led to more significant HbA1c reductions than 1mg of semaglutide

Regulatory data indicates 72% of compounding ingredient manufacturers have received citations for violations

So, what is something that you're grateful for